메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

Xinhua Silk Road: E. China city Longkou moves to forefront of sustainable health & wellness dev. in China

BEIJING, July 26, 2025 -- Longkou, a county-level city in east China, has recently been included into China's top 100 counties by sustainable development capacity of health and wellness industry, according to the annual report on health and wellness industry of China (2024-2025). Longkou is an early starter in bolstering health and wellness industry. It is a demonstrative city for county-wide elderly care service system innovation and health and wellness-based tourism in Shandong Province. In a local elderly care center, 99-year-old Chen Fenglin, who has lived there for five yea
- 김갑성 기자
- 2025-07-26 19:24
중국에서 실시한 남성 성인형 탈모(AGA) 치료를 위한 KX-826 팅크제 1.0%에 대한 제2상 확증 임상시험에서 일차 평가변수 달성

[ 메디채널 김갑성 기자 ] 쑤저우, 중국 2025년 7월 26일 -- 킨토르 제약(Kintor Pharmaceutical Limited, 이하 '회사')이 자체 개발 중인 KX-826 팅크제 1.0%가 남성 성인형 탈모(AGA) 치료를 위한 제2상 확증 임상시험에서 탑라인 결과를 확보했다고 밝혔다. 이번 임상시험 결과, 제2상에서 통계적으로 유의하고 임상적으로 의미 있는 결과를 가진 일차 평가변수를 달성하면서 우수한 유효성과 안전성을 입증했다. 제2상에는 총 90명의 환자가 참여했으며, 분석 결과는 다음과 같다. 위약 그룹 대비 유효성 측면에서 0.5% BID(1일 2회)과 1.0% BID 그룹 모두 통계적으로 임상적으로 유의한 치료적 유효성과 임상 유의성을 보였다. 0.5% BID 그룹의 표적 부위 비솜털 수(TAHC)는 기준선 대비 22.39개/cm² 증가했다. 1.0% BID 그룹의 TAHC는 베이스라인 대비 21.87개/cm² 증가했다. 위약 그룹의 TAHC는 베이스라인 대비 8.73개/cm² 증가했다. 0.5% BID 그룹의 TAHC는 위약 그룹 대비 13.66개/cm² 증가해 통계적으로
- 김갑성 기자
- 2025-07-26 09:52
Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

SUZHOU, China, July 26, 2025 -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.0% for the treatment of AGA has obtained top-line results. Results indicated that the Phase II Stage has reached its primary endpoint with statistically significant and clinically meaningful outcomes, demonstrating excellent efficacy and safety. Analysis results of the 90 patients enrolled in the Phase II Stage showed that: Regarding efficacy, c
- 김갑성 기자
- 2025-07-26 07:30
Shanton Receives Fast Track Designation from US FDA for Refractory Gout Program

SAP-001 is Shanton's lead investigational compound with First- and Best-in-Class potential in uncontrolled gout SINGAPORE and PRINCETON, N.J., July 25, 2025 -- Shanton Pharma, a clinical-stage biotech company developing a novel treatment for gout, today announced that FDA has designated its Investigational New Drug SAP-001 as a Fast Track product for treatment of hyperuricemia in adult patients with gout who are refractory to conventional therapy. "We are excited about the Fast Track designation for SAP-001" says Dr. Wenfeng Miao, Shanton's CMO. "Refractor
- 김갑성 기자
- 2025-07-25 22:59
Phase II Stage Of Pivotal Clinical Trial Of KX-826 Tincture 1.0% For The Treatment Of Male Adult Aga In China Reached Primary Endpoint

SUZHOU, China, July 25, 2025 -- The Kintor Pharmaceutical Limited (the "Company") is pleased to announce that the Phase II Stage of the Pivotal Clinical Trial of its in-house developed and potential first-in-class KX-826 tincture 1.0% for the treatment of AGA has obtained top-line results. Results indicated that the Phase II Stage has reached its primary endpoint with statistically significant and clinically meaningful outcomes, demonstrating excellent efficacy and safety. Analysis results of the 90 patients enrolled in the Phase II Stage showed that: Regarding efficacy, c
- 김갑성 기자
- 2025-07-25 20:30
Amcor announces registered exchange offers

ZURICH, July 25, 2025 -- Amcor plc ("Amcor") (NYSE: AMCR, ASX: AMC) today announced the commencement of offers (the "exchange offers") by Amcor Flexibles North America, Inc., Amcor's wholly-owned subsidiary (the "Issuer") and the guarantors, including Amcor (the "Guarantors"), to exchange: (1) up to $725,000,000 4.800% Guaranteed Senior Notes due 2028 (the "Old 2028 Notes") for a like principal amount of 4.800% Guaranteed Senior Notes due 2028, the offer of which has been registered under the Securities Act of 1933, as amended (the "Secur
- 황정호 기자
- 2025-07-25 20:12
MALAYSIA HEALTHCARE TRAVEL COUNCIL LAUNCHES MYMT 2026, MALAYSIA'S FIRST MEDICAL TOURISM YEAR

KUALA LUMPUR, Malaysia, July 25, 2025 -- The Malaysia Healthcare Travel Council (MHTC) launched Malaysia Year of Medical Tourism (MYMT) 2026 today at the Malaysia International Trade and Exhibition Centre (MITEC). The Honourable Datuk Seri Dr. Dzulkefly Ahmad, Minister of Health Malaysia, officiated the event, unveiling the campaign's logo and tagline, "Healing Meets Hospitality." MYMT 2026 aims to position Malaysia as a premier medical tourism destination by showcasing its advanced healthcare services and hospitality. The campaign also seeks to attract internat
- 김갑성 기자
- 2025-07-25 14:00
Informal caregivers in Singapore seen as undertrained and overwhelmed

Despite nearly all professional caregivers agreeing that informal caregivers can help bridge the demand of caregiving in Singapore to a certain extent (30% large, 45% moderate, 23% small extent), only a quarter of professionals (25%) say that informal caregivers today are "somewhat capable" of providing necessary care, with none believing they are "very capable". Around four in five (79%) professional caregivers say that informal caregivers are either "minimally trained" or not "trained at all" in caregiving; with all professionals agreeing
- 김갑성 기자
- 2025-07-25 12:57
Everest Medicines Announces Share Placement to Raise Approximately HK$1,572.50 Million

SHANGHAI, July 25, 2025 -- Everest Medicines (HKEX 1952.HK, "Everest" or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing, and commercialization of innovative therapeutics, today announced that it has entered into a placing and subscription agreement with the placing agents and its controlling shareholder, CBC Group (the "Sellers"), for a top-up placement of 22,561,000 shares to raise approximately HK$1,572.50 million, representing approximately 6.87% of the total number of Shares in issue as at the date of
- 김갑성 기자
- 2025-07-25 10:30
Global Times: How to care for tens of thousands of seniors in remote mountain villages? This county in East China has a solution

BEIJING, July 25, 2025 -- Life has never been happier for Xu Furong. The 86-year-old resident of Nanliuzhuang village starts each morning with a bit of light housework. Then, hand in hand with her 90-year-old husband, she walks for about 10 minutes, crossing two streets to reach the "senior canteen," which offers elderly residents convenient services at the "Yiyuanhong" Happy Home Livelihood Complex located just across from the village's Party committee office. During the heat of summer, the senior canteen offers a refreshing and comfortable haven. By around
- 김갑성 기자
- 2025-07-25 10:24

이전

31 32 33 34 35 36 37 38 39 40

많이 본 기사

최근기사

2025-09-01_MON

2025-08-31_SUN

2025-08-30_SAT

Global Trade Review Announces GTR Asia 2025 in Singapore - the premier platform for the trade community in the Asia Pacific region - hits over 1,500 registration for September 2-3 23:39

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 09월 01일 09시 00분